Agent View

Machine representations

Inspect the same governed public record as Markdown, structured data, or a retrieval endpoint.

Canonical entity
alpha:company:fa10748c-f43b-4192-a33a-dfa6208f0e21
Schema
alpha.governance.entity.public.v1
Last reviewed
2026-09-16T04:45:56.945262+00:00
Verification
source_reported
Ownership
unclaimed

Markdown

https://registry.alpha.ac/companies/taysha-gene-therapies-inc.md
Open Markdown

Taysha Gene Therapies, Inc.

Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero.

Record

FieldValue
Representationalpha-profile-markdown-v3
ProtocolAlpha Governance Facts Protocol 0.1
Schemaalpha.governance.entity.public.v1
Record versionpublic-1
Canonical entityalpha:company:fa10748c-f43b-4192-a33a-dfa6208f0e21
Entity typeCompany
Canonical URLhttps://registry.alpha.ac/companies/taysha-gene-therapies-inc
PublicationPUBLISHED
Verificationsource_reported
Verification schemaalpha-verification-states-v1
Ownershipunclaimed
Published claims16
Claims under review1
Evidence records3
Conflicts0
Conflicts in internal review0
Observed2026-09-16T04:45:56.945262+00:00
Last reviewed2026-09-16T04:45:56.945262+00:00

Identity

  • Legal name: Taysha Gene Therapies, Inc.
  • Display name: Taysha Gene Therapies, Inc.

Leadership

  • Sean P. Nolan: Chairman of the Board and Chief Executive Officer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:fa10748c-f43b-4192-a33a-dfa6208f0e21:2.
  • Alison Long: Director. Valid from: 2023-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:fa10748c-f43b-4192-a33a-dfa6208f0e21:3.
  • Alison Long, M.D., Ph.D.: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:fa10748c-f43b-4192-a33a-dfa6208f0e21:2.
  • Laura Sepp-Lorenzino: Director. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:fa10748c-f43b-4192-a33a-dfa6208f0e21:3.
  • Laura Sepp-Lorenzino, Ph.D.: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:fa10748c-f43b-4192-a33a-dfa6208f0e21:2.
  • Phillip B. Donenberg: Director. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:fa10748c-f43b-4192-a33a-dfa6208f0e21:3.
  • Phillip B. Donenberg, CPA: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:fa10748c-f43b-4192-a33a-dfa6208f0e21:2.
  • Sean Stalfort: Director. Valid from: 2023-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:fa10748c-f43b-4192-a33a-dfa6208f0e21:3.
  • Sukumar Nagendran: Director. Valid from: 2026-04-22. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:fa10748c-f43b-4192-a33a-dfa6208f0e21:3.
  • Sukumar Nagendran, M.D.: President, Head of Research and Development and Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:fa10748c-f43b-4192-a33a-dfa6208f0e21:2.
  • Kamran Alam: Chief Financial Officer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:fa10748c-f43b-4192-a33a-dfa6208f0e21:2.
  • Sean P. Nolan: Chief Executive Officer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:fa10748c-f43b-4192-a33a-dfa6208f0e21:2.
  • Sukumar Nagendran, M.D.: President and Head of Research and Development. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:fa10748c-f43b-4192-a33a-dfa6208f0e21:2.

Roles

  • PUBLISHED

Governance

  • NOT_ASSERTED

Board committees

  • PUBLISHED

Financials

  • NOT_ASSERTED

Workforce

  • NOT_ASSERTED

Market and index context

  • PUBLISHED

Legal Name

  • Taysha Gene Therapies, Inc.. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:fa10748c-f43b-4192-a33a-dfa6208f0e21:1.

Headquarters

  • US. Publication: UNDER_REVIEW. Verification: source_reported. Assertion: source_reported. Evidence: unlinked, under review.

Entity Status

  • Public listing published. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:fa10748c-f43b-4192-a33a-dfa6208f0e21:1.

Published Fact

  • US. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:fa10748c-f43b-4192-a33a-dfa6208f0e21:1.

Coverage states

FieldValue
IdentityPUBLISHED
BusinessPUBLISHED
LeadershipPUBLISHED
Board and committeesPUBLISHED
GovernanceNOT_ASSERTED
FinancialsNOT_ASSERTED
WorkforceNOT_ASSERTED
OwnershipNOT_ASSERTED
RatingsNOT_PUBLISHED
Market and index contextPUBLISHED

Public sources

Rights

FieldValue
public_retrievalallowed
agent_retrievalallowed
redistributionnot_granted
model_trainingnot_granted
commercial_usenot_specified
relationship_pathfindingnot_granted
direct_contactnot_granted

Limitations

  • Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
  • Only explicitly published canonical company identity and current confirmed public roles are included.
  • Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
  • Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
  • This Company Profile is an identity and evidence record, not an Alpha rating.

Alternate representations